Saskia Neuteboom
About Saskia Neuteboom
Saskia Neuteboom serves as the Senior Director of Clinical Science at Mirati Therapeutics, where she has worked since 2017. She holds a Doctorate in Molecular Biology from Leiden University, where she studied from 1988 to 1994.
Current Role at Mirati Therapeutics
Saskia Neuteboom holds the position of Senior Director, Clinical Science at Mirati Therapeutics. She has been in this role since 2017, contributing to the company's clinical research initiatives. Her work focuses on advancing the understanding of therapeutic approaches and enhancing clinical trial designs. Neuteboom operates from the San Diego, California office, where she leads various projects aimed at improving patient outcomes through innovative treatments.
Previous Experience at Mirati Therapeutics
Before her current role, Saskia Neuteboom served as Director, Clinical Science at Mirati Therapeutics from 2014 to 2017. During her three years in this position, she was involved in the development and execution of clinical strategies. Her experience in this role laid the groundwork for her subsequent promotion to Senior Director, where she continues to influence the direction of clinical science within the organization.
Education and Expertise
Saskia Neuteboom earned her Doctor of Philosophy degree in Molecular Biology from Leiden University. Her studies spanned from 1988 to 1994, providing her with a strong foundation in biological sciences. This academic background supports her expertise in clinical science, particularly in the context of drug development and clinical research methodologies.
Professional Background
Saskia Neuteboom has a substantial background in clinical science, with a focus on the pharmaceutical industry. Her career at Mirati Therapeutics reflects her commitment to advancing cancer therapies. With years of experience in clinical roles, she has developed a comprehensive understanding of the complexities involved in clinical trials and regulatory processes.